Combined immunotherapy with low-dose IL-2 plus IFN-alpha for metastatic renal cell carcinoma: survival benefit for selected patients with lung metastasis and serum sodium level.
暂无分享,去创建一个
Yusuke Nakamura | T. Miki | H. Akaza | T. Fujioka | Y. Tomita | S. Naito | H. Zembutsu | T. Kitamura | T. Tsukamoto | S. Ozono